CervoMed's Phase 2b trial shows neflamapimod reduces dementia progression and plasma GFAP, with significant cognitive ...

Sarepta Therapeutics is showing signs of recovery, driven by its robust pipeline and recent revenue growth, despite past ...

One-time infusion of anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy in 16 patients with metastatic uveal ...

The judge in the Santa Rosa Diocese’s bankruptcy case recently put a small set of lawsuits on the path to trial, where they ...

Significant improvement relative to placebo on primary outcome measure, change in Clinical Dementia Rating Sum of Boxes (CDR-SB), demonstrated in ...

ScotusCrim is a recurring series by Rory Little focusing on intersections between the Supreme Court and criminal law. Please ...

Some data on consumption, production and hiring can be estimated using private sources, but inflation remains a blind spot.

Given the recent proliferation of artificial intelligence patent drafting technology, some in the legal services industry are ...

Immatics (IMTX) announced the presentation of updated data from 16 patients with metastatic uveal melanoma treated with anzu-cel PRAME cell ...

Students and faculty of four micro-campuses in China the University of Arizona closed last month are blasting the school's ...

Mayor Daniel Lurie's administration is defending the process it followed to give a tech company a contract worth up to $5.9 ...

OpenAI is now making an ‘erotic’ version of their app, leaning in to the trend of people using ChatGPT to create AI ...